Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_assertion type Assertion NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_head.
- NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_assertion description "[Regular use of long-acting beta(2)-agonists is not associated with significant tolerance to their bronchodilator action, impairment in the response to albuterol, decreased baseline pulmonary function, increased response to methacholine, or increased risk of adverse cardiac events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_provenance.
- NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_assertion evidence source_evidence_literature NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_provenance.
- NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_assertion SIO_000772 16387577 NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_provenance.
- NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_assertion wasDerivedFrom befree-20150227 NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_provenance.
- NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_assertion wasGeneratedBy ECO_0000203 NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_provenance.